Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
Abstract Background The 'placebo effect' and 'nocebo effect' are phenomena whereby beneficial (placebo) or adverse (nocebo) effects result from the expectation that an inert substance will relieve or cause a particular symptom. These terms are often inappropriately applied to eff...
Saved in:
Main Authors: | Peter E. Penson (Author), G. B. John Mancini (Author), Peter P. Toth (Author), Seth S. Martin (Author), Gerald F. Watts (Author), Amirhossein Sahebkar (Author), Dimitri P. Mikhailidis (Author), Maciej Banach (Author), on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
by: Peter E. Penson, et al.
Published: (2022) -
Effects of statins on mitochondrial pathways
by: Hamid Mollazadeh, et al.
Published: (2021) -
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
by: Amirhossein Sahebkar, et al.
Published: (2020) -
The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials
by: Babak Alikiaii, et al.
Published: (2021) -
Are statins overprescribed?
by: Richard M Fleming, et al.
Published: (2020)